<DOC>
	<DOCNO>NCT00002266</DOCNO>
	<brief_summary>To compare AS-101 dose schedule ( week ; 3 time week ; 5 time week ; 5 time per week alternate week ) effect clinical immunology virus burden AIDS AIDS relate complex ( ARC ) patient .</brief_summary>
	<brief_title>An Open Parallel Study Determine Optimum Dosing Schedule AS-101 AIDS/ARC Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ammonium trichloro ( dioxoethylene-O , O'- ) tellurate</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Standard therapy infection . Acyclovir . Ganciclovir . Allowed permission WyethAyerst medical monitor : Zidovudine ( AZT ) . Immunomodulators . Specific therapy malignancy ( include Kaposi 's sarcoma ) . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Evidence severe liver dysfunction ( serum albumin &lt; 3 g/dl , SGOT SGPT &gt; 5 x upper limit normal , prothrombin time &gt; 15 second ) , gastrointestinal , renal , respiratory , endocrine , hematologic , cardiovascular system abnormality psychiatric disorder abnormality secondary AIDS AIDS relate complex ( ARC ) . Evidence AIDSrelated central nervous system involvement . Disseminated Kaposi 's sarcoma . Concurrent Medication : Excluded without permission WyethAyerst medical monitor : Zidovudine ( AZT ) . Immunomodulators . Specific therapy malignancy ( include Kaposi 's sarcoma ) . Patients follow exclude : Evidence major system abnormality abnormalities secondary AIDS AIDS relate complex . Concomitant condition specify Patient Exclusion Coexisting Conditions . Unlikely unable comply requirement protocol . Prior Medication : Excluded within 4 week study entry : Systemic antiviral agent . Immunosuppressive agent . Immune stimulators BCG vaccine , isoprinosine , immunomodulators . Patients must : Have diagnosis AIDS AIDS relate complex ( ARC ) . Demonstrate intolerance refusal take zidovudine ( AZT ) . Provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 1990</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>ammonium trichloro ( dioxoethylene-O , O'- ) tellurute</keyword>
</DOC>